doi: 10.3389/fphar.2025.1516601 Received 24 October 2024 Accepted 04 February 2025 Published 24 February 2025 Volume 16 - 2025 Edited by Ewa Litwa, Polish Academy of Sciences, Poland Reviewed by Stefano Comai, University of Padua, Italy Archita Venugopal Menon, Beam Therapeutics, United States Updates Copyright 2025 Zhao, Ren, Luo, Li, Cheng, Wen, Wu and Zhou
Why combine NAD and Glutathione
Al-Damluji S, Iveson T, Thomas JM, Pendlebury DJ, Rees LH, Besser GM
J Basic Clin Physiol Pharmacol
Proteins and amino acids may also be elective targets of oxidant-mediated injury, and an increased formation of 3-chlortyrosine (a specific marker of MPO-catalyzed oxidation) has been demonstrated in HD patients